TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05838703

Tiotropium Handihaler vs. Tiotropium Respimat in COPD

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Study halted prematurely due to funding, prior to enrollment of first participant”

The sponsor’s own words in the registry.

Life of this trial

202320242025Registered2023-03-24Planned start2023-05-01 (planned)Withdrawn (as of)2023-06-15

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Duke University
Sponsor type
University, hospital or other
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
tiotropium bromide inhalation powder (Spiriva HandiHaler); tiotropium bromide (Spiriva Respimat); Hyperpolarized 129XeMRI
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.